Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2025-12-25 @ 3:54 AM
NCT ID:
NCT03733002
Eligibility Criteria:
Inclusion Criteria:
1. Acute ischemic stroke.
2. 18 years ≤ age ≤ 80 years.
3. Within 24 hours from symptom onset.
4. Baseline NIHSS range 5 from 20.
5. Provision of informed consent.
Exclusion Criteria:
1. Not suitable for taking this medicine after dialectic of traditional Chinese medical doctor.
2. Suffering from intracranial tumors, encephalitis, subarachnoid hemorrhage and other brain organic diseases.
3. Receive thrombolysis or endovascular treatment.
4. mRS\>1 at randomization (pre-morbid historical assessment).
5. Thrombocytopenia(\<100×10\*9/L) , hematologic diseases and other systemic bleeding tendency.
6. Sleepy head (GCS≤7).
7. Alanine transaminase \> 1.5 times normal upper limit or Aspartate aminotransferase \> 1.5 times normal upper limit.
8. Glomerular filtration rate\<60 ml/min/1.73m2.
9. Patients who have been taking AngongNiuhuang pills within 3 months.
10. Pregnancy or lactation, women in childbearing age with negative pregnancy test refuse to accept contraception.
11. Participate in clinical studies of other research drugs within the last 30 days.
12. Patients with a life expectancy of less than three months.
13. Incapable to follow this study for mental illness, cognitive or emotional disorders.
14. Unsuitable for this study in the opinion of the investigators.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03733002
Study Brief:
Protocol Section:
NCT03733002